Literature DB >> 9632807

BAZF, a novel Bcl6 homolog, functions as a transcriptional repressor.

S Okabe1, T Fukuda, K Ishibashi, S Kojima, S Okada, M Hatano, M Ebara, H Saisho, T Tokuhisa.   

Abstract

The BCL6 gene, which has been identified from the chromosomal translocation breakpoint in B-cell lymphomas, functions as a sequence-specific transcriptional repressor. We cloned a novel Bcl6-homologous gene, BAZF (encoding Bcl6-associated zinc finger protein). The predicted amino acid sequence of BAZF indicated that the BTB/POZ domain and the five repeats of the Krüppel-like zinc finger motif are located in the NH2-terminal region and the COOH-terminal region, respectively. BAZF associated with Bcl6 at the BTB/POZ domain and localized in the nucleus. Since zinc finger motifs of BAZF were 94% identical to those of Bcl6 at the amino acid level, BAZF bound specifically to the DNA-binding sequence of Bcl6 and functioned as a transcriptional repressor. The repressor activity was associated with both the BTB/POZ domain and the middle portion of BAZF. The 17-amino-acid sequence in the middle portion was completely conserved between BAZF and Bcl6, and the conserved region was critical for the repressor activity. Expression of BAZF mRNA, like that of Bcl6 mRNA, was induced in activated lymphocytes as an immediate-early gene. Therefore, the biochemical character of BAZF is similar to that of Bcl6 although the tissue expression pattern of BAZF differs from that of Bcl6. This is apparently the first report of a gene family whose members encode zinc finger proteins with the BTB/POZ domain.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9632807      PMCID: PMC109007          DOI: 10.1128/MCB.18.7.4235

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  46 in total

1.  BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor.

Authors:  C C Chang; B H Ye; R S Chaganti; R Dalla-Favera
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

2.  Transcriptional repression by the proto-oncogene BCL-6.

Authors:  V L Seyfert; D Allman; Y He; L M Staudt
Journal:  Oncogene       Date:  1996-06-06       Impact factor: 9.867

3.  Bcl-2, Bcl-XL and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death.

Authors:  D C Huang; S Cory; A Strasser
Journal:  Oncogene       Date:  1997-01-30       Impact factor: 9.867

4.  Physical and functional interactions between Stat5 and the tyrosine-phosphorylated receptors for erythropoietin and interleukin-3.

Authors:  H Chin; N Nakamura; R Kamiyama; N Miyasaka; J N Ihle; O Miura
Journal:  Blood       Date:  1996-12-15       Impact factor: 22.113

5.  The BCL6 gene is predominantly expressed in keratinocytes at their terminal differentiation stage.

Authors:  T Yoshida; T Fukuda; S Okabe; M Hatano; T Miki; S Hirosawa; N Miyasaka; K Isono; T Tokuhisa
Journal:  Biochem Biophys Res Commun       Date:  1996-11-01       Impact factor: 3.575

6.  TRAF5, an activator of NF-kappaB and putative signal transducer for the lymphotoxin-beta receptor.

Authors:  H Nakano; H Oshima; W Chung; L Williams-Abbott; C F Ware; H Yagita; K Okumura
Journal:  J Biol Chem       Date:  1996-06-21       Impact factor: 5.157

7.  Control of inflammation, cytokine expression, and germinal center formation by BCL-6.

Authors:  A L Dent; A L Shaffer; X Yu; D Allman; L M Staudt
Journal:  Science       Date:  1997-04-25       Impact factor: 47.728

8.  Multiple domains participate in distance-independent LAZ3/BCL6-mediated transcriptional repression.

Authors:  O Albagli; P Dhordain; F Bernardin; S Quief; J P Kerkaert; D Leprince
Journal:  Biochem Biophys Res Commun       Date:  1996-03-27       Impact factor: 3.575

9.  The ZiN/POZ domain of ZF5 is required for both transcriptional activation and repression.

Authors:  J Kaplan; K Calame
Journal:  Nucleic Acids Res       Date:  1997-03-15       Impact factor: 16.971

10.  Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B cell lymphoma.

Authors:  B H Ye; S Chaganti; C C Chang; H Niu; P Corradini; R S Chaganti; R Dalla-Favera
Journal:  EMBO J       Date:  1995-12-15       Impact factor: 11.598

View more
  25 in total

1.  Negative autoregulation of BCL-6 is bypassed by genetic alterations in diffuse large B cell lymphomas.

Authors:  Xing Wang; Zhiping Li; Akira Naganuma; B Hilda Ye
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-29       Impact factor: 11.205

2.  In-depth mutational analysis of the promyelocytic leukemia zinc finger BTB/POZ domain reveals motifs and residues required for biological and transcriptional functions.

Authors:  A Melnick; K F Ahmad; S Arai; A Polinger; H Ball; K L Borden; G W Carlile; G G Prive; J D Licht
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

Review 3.  POK/ZBTB proteins: an emerging family of proteins that regulate lymphoid development and function.

Authors:  Sung-Uk Lee; Takahiro Maeda
Journal:  Immunol Rev       Date:  2012-05       Impact factor: 12.988

4.  ZENON, a novel POZ Kruppel-like DNA binding protein associated with differentiation and/or survival of late postmitotic neurons.

Authors:  Hélène Kiefer; Fabienne Chatail-Hermitte; Philippe Ravassard; Elisa Bayard; Isabelle Brunet; Jacques Mallet
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

5.  BCL6b mediates the enhanced magnitude of the secondary response of memory CD8+ T lymphocytes.

Authors:  Peter M Manders; Patricia J Hunter; Aino I Telaranta; James M Carr; Jennifer L Marshall; Marlene Carrasco; Yusuke Murakami; Michael J Palmowski; Vincenzo Cerundolo; Susan M Kaech; Rafi Ahmed; Douglas T Fearon
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-15       Impact factor: 11.205

6.  Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155.

Authors:  Rebecca L Skalsky; Mark A Samols; Karlie B Plaisance; Isaac W Boss; Alberto Riva; M Cecilia Lopez; Henry V Baker; Rolf Renne
Journal:  J Virol       Date:  2007-09-19       Impact factor: 5.103

7.  Epigenetic silencing BCL6B induced colorectal cancer proliferation and metastasis by inhibiting P53 signaling.

Authors:  Sui Hu; Baoping Cao; Meiying Zhang; Enqiang Linghu; Qimin Zhan; Malcolm V Brock; James G Herman; Gaoping Mao; Mingzhou Guo
Journal:  Am J Cancer Res       Date:  2015-01-15       Impact factor: 6.166

8.  Recruitment of SMRT/N-CoR-mSin3A-HDAC-repressing complexes is not a general mechanism for BTB/POZ transcriptional repressors: the case of HIC-1 and gammaFBP-B.

Authors:  S Deltour; C Guerardel; D Leprince
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

9.  BCoR, a novel corepressor involved in BCL-6 repression.

Authors:  K D Huynh; W Fischle; E Verdin; V J Bardwell
Journal:  Genes Dev       Date:  2000-07-15       Impact factor: 11.361

Review 10.  Effectors and memories: Bcl-6 and Blimp-1 in T and B lymphocyte differentiation.

Authors:  Shane Crotty; Robert J Johnston; Stephen P Schoenberger
Journal:  Nat Immunol       Date:  2010-01-19       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.